Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Inpegsomatropin - Xiamen Amoytop Biotech

Next Previous
Drug Profile

Inpegsomatropin - Xiamen Amoytop Biotech

Alternative Names: Y-shape pegylated somatropin - Xiamen Amoytop Biotech; YPEG-rhGH; YPEG-somatropin - Xiamen Amoytop Biotech

Latest Information Update: 21 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Xiamen Amoytop Biotech
  • Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
  • Mechanism of Action Human growth hormone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Short stature
  • Phase II/III Somatotropin deficiency

Most Recent Events

  • 07 Apr 2025 Phase-III clinical trials in Short stature (In children, Treatment-naive) in China (SC) (NCT06927310)
  • 27 Sep 2022 Y-shape pegylated somatropin is still in phase-II/III trials for Somatotropin deficiency in China
  • 31 Aug 2012 Xiamen Amoytop Biotech completes a phase I trial in Healthy volunteers in China (NCT01339182)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top